Portfolio (Quarterly)
Guide ↗
SUPERSTRING CAPITAL MANAGEMENT LP
· CIK 0001931118| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | COGT | COGENT BIOSCIENCES INC | Healthcare | 225,158.0 | $8.7M | 6.19% | -141K | -38.5% | $38.49 | -2.1% |
| 2 | URGN | UROGEN PHARMA LTD | Healthcare | 387,371.0 | $7.0M | 4.98% | -331K | -46.1% | $17.98 | +122.5% |
| 3 | SION | SIONNA THERAPEUTICS INC | Healthcare | 141,024.0 | $5.7M | 4.04% | -40K | -21.9% | $40.09 | +14.9% |
| 4 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 5,186.0 | $3.1M | 2.20% | -4K | -45.1% | $592.98 | -10.6% |
| 5 | CABA | CABALETTA BIO INC | Healthcare | 1,066,239.0 | $2.9M | 2.05% | -1.2M | -52.7% | $2.69 | -3.0% |
| 6 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 11,217.0 | $1.9M | 1.35% | -26K | -70.0% | $169.02 | +39.1% |
| 7 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 115,234.0 | $1.5M | 1.04% | -140K | -54.9% | $12.67 | -16.7% |
| 8 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 258,269.0 | $1.2M | 0.82% | -722K | -73.7% | $4.47 | +33.1% |
| 9 | — | BRIGHT MINDS BIOSCIENCES INC | — | 13,311.0 | $971K | 0.69% | -34K | -71.8% | $72.97 | — |
| 10 | TARA | PROTARA THERAPEUTICS INC | Healthcare | 121,457.0 | $633K | 0.45% | -239K | -66.3% | $5.21 | -22.9% |
| 11 | IPSC | CENTURY THERAPEUTICS INC | Healthcare | 119,308.0 | $270K | 0.19% | -344K | -74.2% | $2.26 | -3.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%